PTEN and CLOVE syndrome: Support for a non-cell-autonomous mechanism underlying hamartoma formation comes from the demonstration that CLOVES syndrome patients, who also develop hamartomas, have activating mutations in PIK3CA, which phenocopies PTEN loss (Kurek et al., 2012b).